CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30391% above fair value

$6.27+0.00 (0.00%)

Close on Nov 12, 2026Market cap $313.79MP/E –Yield –

CapsoVision operating margin

Operating margin is operating income as a percentage of revenue.

CapsoVision's operating margin for the twelve months ending Sep 30, 2026 was -212.1%. For fiscal 2025 it was -188.3%, against -169.4% the year before.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-188.3%	−18.8
FY2024	Dec 31, 2024	-169.4%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-207.0%	+19.7
Q2 FY2026	Jun 30, 2026	-208.1%	−67.8
Q1 FY2026	Mar 31, 2026	-254.0%	−60.7
Q4 FY2025	Dec 31, 2025	-190.5%	−56.3
Q3 FY2025	Sep 30, 2025	-226.7%	−31.0
Q2 FY2025	Jun 30, 2025	-140.3%	+45.1
Q1 FY2025	Mar 31, 2025	-193.4%	–
Q4 FY2024	Dec 31, 2024	-134.2%	–
Q3 FY2024	Sep 30, 2024	-195.7%	–
Q2 FY2024	Jun 30, 2024	-185.4%	–